Bacteria to alleviate metabolic syndrome.

Anhê, Fernando F; Schertzer, Jonathan D; Marette, André

Anhê, Fernando F; Schertzer, Jonathan D; Marette, André.

Affiliation

Anhê FF; Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute and Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
Schertzer JD; Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute and Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
Marette A; Department of Medicine, Faculty of Medicine, Cardiology Axis of the Québec Heart and Lung Institute and Institute of Nutrition and Functional Foods, Laval University, Québec City, Quebec, Canada. andre.marette@criucpq.ulaval.ca.

Nat Med ; 25(7): 1031-1033, 2019 07.

Article in En | MEDLINE | ID: mdl-31263287

Subject(s)

Metabolic Syndrome/therapy; Probiotics/therapeutic use; Verrucomicrobia; Humans; Leukocyte Count

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Probiotics / Metabolic Syndrome / Verrucomicrobia Limits: Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2019 Document type: Article Affiliation country: Canada Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google